Scarica l'app Stockscreener
2.19
2.23%
-0.05
Dopo l'orario di chiusura:
2.15
-0.04
-1.83%
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché INBS Giù?
Forum
Previsione
Frazionamento azionario
Intelligent Bio Solutions Inc Borsa (INBS) Ultime notizie
A fingerprint drug test company will discuss its FDA submission Sept. 24 - Stock Titan
Intelligent Bio Solutions submits FDA application for codeine test By Investing.com - Investing.com South Africa
Intelligent Bio Solutions Files FDA 510(k) for U.S. Market Entry - Minichart
INBS Looks 7.4% Undervalued on GF Value™ Amid Challenging Price-to-Sales Dynamics - GuruFocus
Intelligent Bio Solutions submits FDA 510(k) for fingerprint drug screen after clinical studies show >98% accuracy - TradingView
Intelligent Bio Solutions submits FDA application for codeine test - Investing.com
Intelligent Bio Solutions Submits FDA 510(k) for Drug Screening System to Detect Codeine - quiverquant.com
Intelligent Bio Solutions Submits FDA 510(k) Package for Intelligent Fingerprinting Drug Screening System, Seeking U.S. Market Clearance - marketscreener.com
Intelligent Bio Submits Comprehensive Clinical Data to Enter US Drug Screening Market - Benzinga
Intelligent Bio Solutions Raises Up to $15M in Private Placement - Minichart
Intelligent Bio Solutions Completes $5 Million Private Placement - TipRanks
Intelligent Bio Solutions Raises $5 Million in Private Placement With Warrants - TradingView
INBS|Intelligent Bio Solutions Inc|Price:2.300|Chg%:-0.170 - TradingKey
Intelligent Bio Solutions Inc. announced that it has received $4.999998 million in funding - marketscreener.com
Intelligent Bio Solutions posts >98% accuracy in multi-site study, targets Sept 2026 510(k) - TradingView
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Intelligent Bio Solutions Inc. announced that it expects to receive $4.999998 million in funding - marketscreener.com
INBS Stock Draws Traders As FDA 510(k) Milestones Pile Up - StocksToTrade
INBS Stock Steadies As FDA Milestones And Revenue Growth Stack Up - timothysykes.com
INBS Looks 3.4% Overvalued on GF Value™ - GuruFocus
Intelligent Bio Solutions reports improved drug screening accuracy By Investing.com - Investing.com India
Intelligent Bio Solutions raises $5M in private placement By Investing.com - Investing.com Canada
Intelligent Bio Solutions reports improved drug screening accuracy - Investing.com
Intelligent Bio Solutions Achieves Above 98% Accuracy in Method Comparison Study, Supporting Planned 2026 FDA 510(k) Submission - The Manila Times
Intelligent Bio Solutions Announces Private Placement of up to $15 Million to a Single Existing Institutional Investor Priced At-the-Market Under Nasdaq Rules - The Manila Times
A fingerprint drug test produced no false positives. Intelligent Bio Solutions expects an FDA filing in September. - Stock Titan
Press Release: Intelligent Bio Solutions Announces Private Placement of up to $15 Million to a Single Existing Institutional Investor Priced At-the-Market Under Nasdaq Rules - Moomoo
Intelligent Bio Solutions Inc (INBS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Intelligent Bio Solutions earnings missed by $4.88, revenue fell short of estimates - Investing.com Canada
Intelligent (INBS) Range: Posts a 1.31% Loss to $2.63 in the Latest Reading; Chart View: $2.50 and $2.76 Define the Nearby Reference Levels in the Current UpdateSize Factor - vinanet.vn
Intelligent Bio Solutions completes clinical data collection for FDA 510(k) - scanx.trade
INBS Looks 0.4% Overvalued on GF Value™ - GuruFocus
Intelligent Bio Solutions Revenue Rises 38% to $4.2 Million in Fiscal 2026 - Moomoo
Intelligent Bio Solutions resolves all cybersecurity review items ahead of H2 2026 FDA filing - scanx.trade
Intelligent Bio Solutions revenue rises 38% to $4.2 million - grafa.com
BRIEF-Intelligent Bio Solutions Reports Fiscal 2026 Full-Year Revenue Growth Of 38% Year-Over-Year, Driven By Reader Installed Base And High-Margin Cartridge Growth - Bitget
Form 8K Intelligent Bio Solutions Inc For: 19 August By Investing.com - Investing.com Nigeria
Intelligent Bio Solutions Inc. Reports Earnings Results for the Full Year Ended June 30, 2026 - marketscreener.com
INBS FY26 Results: Revenue up 38% to $4.2M, margin expands to 48.6% - scanx.trade
Intelligent Bio Solutions Revenue Jumps 38% as Gross Margin Expands 778 Basis Points - Minichart
Intelligent Bio Solutions | 10-K: Annual report - Moomoo
Intelligent Bio Solutions Reports Fiscal 2026 Revenue Up 38% to $4.22M, Gross Margin 48.63% - TradingView
INBS: Revenue up 38% to $4.2M, gross margin 48.63%, FDA submission on track for late 2026 - TradingView
INTELLIGENT BIO SOLUTIONS INC. FY 2026: Revenue $4.22M, EPS $(8.44) — 10-K Summary - TradingView
Intelligent Bio Solutions Reports Fiscal 2026 Full-Year Revenue Growth Of 38% Year-Over-Year, Driven By Reader Installed Base And High-Margin Cartridge Growth - TradingView
Intelligent Bio (NASDAQ: INBS) warns on cash and survival - Stock Titan
Intelligent Bio Solutions grows to 502 customers as net loss widens to $12.5M - Stock Titan
Intelligent Bio Solutions Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Intelligent Bio Solutions (NASDAQ:INBS): Can Commercial Adoption Accelerate? - Kalkine Media
Intelligent Bio Solutions Shares Surge Monday: What's Driving the Action? - TradingView
Intelligent Bio Solutions receives ISO 13485:2016 recertification - Investing.com
Intelligent Bio Solutions receives ISO 13485:2016 recertification By Investing.com - Investing.com Canada
Intelligent Bio Solutions Strengthens Quality Management Credentials with ISO Recertification - The Manila Times
A Fingerprint Drug Test Aligns With the FDA's New Regulation—What's Next? - Stock Titan
What Should Readers Watch in Intelligent Bio Solutions (NASDAQ:INBS) as Diagnostic Adoption Comes Into Focus? - Kalkine Media
INBS Drops 7.67% to $2.77 as Intelligent Bio Solutions Approaches Key SupportNews Sentiment - vinanet.vn
Intelligent Bio Solutions (INBS) gets 5.91% ownership update from Armistice Capital - Stock Titan
Intelligent Bio Solutions (INBS) Surges 15.35% to $2.93 — Testing Key Resistance at $3.08Skew Index - Vinanet
2.29%
0.75%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):